GK Raju, PhD is Light Pharma CEO, and Research Affiliate, Massachusetts Institute of Technology.
ICH Q9: Attaining a Quality-Business Synergy through Quality Risk Management, ROI Analysis, and Highly Capable Facilities
This paper explores the relationship between investing in pharmaceutical manufacturing risk reduction and meeting business objectives.